Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer and Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05061017
What this trial is testing

Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
NSCLCMetastatic Colorectal CarcinomaRefractory Melanoma
Diwakar Davar 13
Not applicableLooking for participantsNCT07327489
What this trial is testing

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Who this might be right for
CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more
Elephas 2,000
Early research (Phase 1)Study completedNCT05578820
What this trial is testing

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Who this might be right for
SarcomaMelanomaSquamous Cell Carcinoma of Head and Neck+5 more
Gene Surgery LLC 21
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00861107
What this trial is testing

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Who this might be right for
Metastatic Cancer
Mirror Biologics, Inc. 50
Not applicableStudy completedNCT02043184
What this trial is testing

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Who this might be right for
Prostatic NeoplasmsBreast NeoplasmsColorectal Neoplasms+2 more
Michigan State University 322
Large-scale testing (Phase 3)Study completedNCT04157985
What this trial is testing

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLCBladder Cancer+10 more
Dan Zandberg 161
Testing effectiveness (Phase 2)Study completedNCT02327078
What this trial is testing

The Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Who this might be right for
B-cell MalignanciesColorectal Cancer (CRC)Head and Neck Cancer+5 more
Incyte Corporation 307
Early research (Phase 1)UnknownNCT00986661
What this trial is testing

Assess PV-10 Chemoablation of Cancer of the Liver

Who this might be right for
Cancer Metastatic to the LiverHepatocellular CarcinomaMetastatic Melanoma+7 more
Provectus Biopharmaceuticals, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Post-approval studies (Phase 4)Study completedNCT04074460
What this trial is testing

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Who this might be right for
Cancer, BreastCancer ColorectalCancer Prostate+3 more
Peter MacCallum Cancer Centre, Australia 169
Not applicableLooking for participantsNCT05539677
What this trial is testing

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Who this might be right for
Malignant Solid TumorsPrimary Brain TumorMelanoma+4 more
N.N. Petrov National Medical Research Center of Oncology 1,000
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Next Page